NASDAQ: ICCM
Icecure Medical Ltd Stock

$1.36-0.01 (-0.73%)
Updated Feb 14, 2025
ICCM Price
$1.36
Fair Value Price
-$0.85
Market Cap
$74.50M
52 Week Low
$0.48
52 Week High
$1.45
P/E
-4.77x
P/B
7.41x
P/S
8.61x
PEG
N/A
Dividend Yield
N/A
Revenue
$3.67M
Earnings
-$13.83M
Gross Margin
43.7%
Operating Margin
-397.33%
Profit Margin
-376.8%
Debt to Equity
0.52
Operating Cash Flow
-$11M
Beta
0.73
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ICCM Overview

IceCure Medical Ltd. develops medical devices to cryoablate (freeze) tumors in the human body. It offers the ProSense system, a cryoablation solution for the treatment of breast tumors. Icecure Medical supports investigator-initiated studies at various academic institutions. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine ICCM's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

D
Value
C
Growth
C
Momentum
C
Sentiment
C
Safety
F
Financials
D
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Device

Industry Rating
D
ICCM
Ranked
#82 of 129

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$31.89A
$10.41A
$47.68A
View Top Medical Device Stocks

Be the first to know about important ICCM news, forecast changes, insider trades & much more!

ICCM News

Overview

Due Diligence Score

Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ICCM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ICCM ($1.36) is overvalued by 259.87% relative to our estimate of its Fair Value price of -$0.85 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
ICCM ($1.36) is not significantly undervalued (259.87%) relative to our estimate of its Fair Value price of -$0.85 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ICCM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ICCM due diligence checks available for Premium users.

Valuation

ICCM fair value

Fair Value of ICCM stock based on Discounted Cash Flow (DCF)

Price
$1.36
Fair Value
-$0.85
Undervalued by
259.87%
ICCM ($1.36) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ICCM ($1.36) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ICCM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ICCM price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-4.77x
Industry
42.37x
Market
37.92x

ICCM price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
7.41x
Industry
4.36x
ICCM is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ICCM's financial health

Profit margin

Revenue
$662.0k
Net Income
-$4.1M
Profit Margin
-626.7%
ICCM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ICCM's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$15.3M
Liabilities
$5.2M
Debt to equity
0.52
ICCM's short-term assets ($13.34M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ICCM's short-term assets ($13.34M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ICCM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$3.2M
Investing
$805.0k
Financing
$3.4M
ICCM's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ICCM vs Medical Device Stocks

TickerZen RatingMarket Cap1d %P/EP/B
ICCMC$74.50M-0.73%-4.77x7.41x
NSPRC$76.95M+3.15%-4.10x1.86x
CTSOC$71.08M-0.76%-3.61x5.47x
XTNTD$83.27M+0.34%-4.61x1.82x
MGRMD$85.09M-7.81%-5.28x4.89x

Icecure Medical Stock FAQ

What is Icecure Medical's quote symbol?

(NASDAQ: ICCM) Icecure Medical trades on the NASDAQ under the ticker symbol ICCM. Icecure Medical stock quotes can also be displayed as NASDAQ: ICCM.

If you're new to stock investing, here's how to buy Icecure Medical stock.

What is the 52 week high and low for Icecure Medical (NASDAQ: ICCM)?

(NASDAQ: ICCM) Icecure Medical's 52-week high was $1.45, and its 52-week low was $0.48. It is currently -6.21% from its 52-week high and 183.33% from its 52-week low.

How much is Icecure Medical stock worth today?

(NASDAQ: ICCM) Icecure Medical currently has 54,778,879 outstanding shares. With Icecure Medical stock trading at $1.36 per share, the total value of Icecure Medical stock (market capitalization) is $74.50M.

Icecure Medical stock was originally listed at a price of $11.05 in Aug 27, 2021. If you had invested in Icecure Medical stock at $11.05, your return over the last 3 years would have been -87.69%, for an annualized return of -50.26% (not including any dividends or dividend reinvestments).

How much is Icecure Medical's stock price per share?

(NASDAQ: ICCM) Icecure Medical stock price per share is $1.36 today (as of Feb 14, 2025).

What is Icecure Medical's Market Cap?

(NASDAQ: ICCM) Icecure Medical's market cap is $74.50M, as of Feb 16, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Icecure Medical's market cap is calculated by multiplying ICCM's current stock price of $1.36 by ICCM's total outstanding shares of 54,778,879.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.